6-Mar-2026 7:19 AM CST - Tokenist Why Bristol-Myers Squibb Remains a Top Healthcare Dividend Stock Pick Bristol-Myers Squibb offers a 4%+ dividend yield backed by steady payout growth and strong cash flow, making it one of the more attractive income stocks in the healthcare sector.
27-Feb-2026 2:00 PM CST - Yahoo Finance Is Bristol-Myers Squibb Stock Underperforming the Nasdaq? Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock's prospects.
24-Feb-2026 1:46 AM CST - Yahoo Finance FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now. On February 17, Bristol Myers Squibb announced that the FDA accepted its NDA for iberdomide, which is an investigational treatment for patients with relapsed or refractory multiple myeloma/RRMM.
19-Feb-2026 11:07 AM CST - Yahoo Finance What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)? Bristol-Myers Squibb Company (NYSE:BMY) is one of the best immunotherapy stocks to buy according to hedge funds. Bristol-Myers Squibb Company (NYSE:BMY) announced on February 12 plans to become an inaugural partner to Life Science Cares in support of its national campaign in fighting food insecurity.
13-Feb-2026 4:08 AM CST - Yahoo Finance Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus Bristol-Myers Squibb (NYSE:BMY) has outlined a broad pipeline refresh that includes multiple recent product launches and the announcement of a new R&D facility. The company has agreed to acquire Orbital Therapeutics,
12-Feb-2026 12:00 PM CST - Benzinga What Does the Market Think About Bristol-Myers Squibb Co? Comparing Bristol-Myers Squibb Co's Short Interest Against Its Peers. Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is perfo
9-Feb-2026 5:44 PM CST - Yahoo Finance Assessing Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Pipeline Optimism Earnings-triggered move in Bristol-Myers Squibb stock Bristol-Myers Squibb (BMY) is back in focus after its latest earnings release, which showed higher profitability, flat full year revenue, and guidance that came in above analyst expectations.
6-Feb-2026 2:39 PM CST - Seeking Alpha Bristol-Myers Squibb: A Dividend Gem With Hidden Upside In 2026 Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian thesis. Read the latest analysis on the stock here.
Latest BMY Trades by Congress Members
19-DEC-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
6-Mar-2026 7:19 AM CST - Tokenist Why Bristol-Myers Squibb Remains a Top Healthcare Dividend Stock Pick Bristol-Myers Squibb offers a 4%+ dividend yield backed by steady payout growth and strong cash flow, making it one of the more attractive income stocks in the healthcare sector.
27-Feb-2026 2:00 PM CST - Yahoo Finance Is Bristol-Myers Squibb Stock Underperforming the Nasdaq? Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock's prospects.
24-Feb-2026 1:46 AM CST - Yahoo Finance FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now. On February 17, Bristol Myers Squibb announced that the FDA accepted its NDA for iberdomide, which is an investigational treatment for patients with relapsed or refractory multiple myeloma/RRMM.
19-Feb-2026 11:07 AM CST - Yahoo Finance What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)? Bristol-Myers Squibb Company (NYSE:BMY) is one of the best immunotherapy stocks to buy according to hedge funds. Bristol-Myers Squibb Company (NYSE:BMY) announced on February 12 plans to become an inaugural partner to Life Science Cares in support of its national campaign in fighting food insecurity.
13-Feb-2026 4:08 AM CST - Yahoo Finance Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus Bristol-Myers Squibb (NYSE:BMY) has outlined a broad pipeline refresh that includes multiple recent product launches and the announcement of a new R&D facility. The company has agreed to acquire Orbital Therapeutics,
12-Feb-2026 12:00 PM CST - Benzinga What Does the Market Think About Bristol-Myers Squibb Co? Comparing Bristol-Myers Squibb Co's Short Interest Against Its Peers. Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is perfo
9-Feb-2026 5:44 PM CST - Yahoo Finance Assessing Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Pipeline Optimism Earnings-triggered move in Bristol-Myers Squibb stock Bristol-Myers Squibb (BMY) is back in focus after its latest earnings release, which showed higher profitability, flat full year revenue, and guidance that came in above analyst expectations.
6-Feb-2026 2:39 PM CST - Seeking Alpha Bristol-Myers Squibb: A Dividend Gem With Hidden Upside In 2026 Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian thesis. Read the latest analysis on the stock here.
